1. Home
  2. PTIX vs AGMH Comparison

PTIX vs AGMH Comparison

Compare PTIX & AGMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • AGMH
  • Stock Information
  • Founded
  • PTIX 1994
  • AGMH 2015
  • Country
  • PTIX United States
  • AGMH Hong Kong
  • Employees
  • PTIX N/A
  • AGMH N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • AGMH EDP Services
  • Sector
  • PTIX Health Care
  • AGMH Technology
  • Exchange
  • PTIX Nasdaq
  • AGMH Nasdaq
  • Market Cap
  • PTIX 2.0M
  • AGMH 1.8M
  • IPO Year
  • PTIX 2016
  • AGMH 2018
  • Fundamental
  • Price
  • PTIX $0.42
  • AGMH $0.05
  • Analyst Decision
  • PTIX
  • AGMH
  • Analyst Count
  • PTIX 0
  • AGMH 0
  • Target Price
  • PTIX N/A
  • AGMH N/A
  • AVG Volume (30 Days)
  • PTIX 324.0K
  • AGMH 73.1M
  • Earning Date
  • PTIX 05-14-2025
  • AGMH 04-15-2025
  • Dividend Yield
  • PTIX N/A
  • AGMH N/A
  • EPS Growth
  • PTIX N/A
  • AGMH N/A
  • EPS
  • PTIX N/A
  • AGMH N/A
  • Revenue
  • PTIX N/A
  • AGMH $64,998,081.00
  • Revenue This Year
  • PTIX N/A
  • AGMH N/A
  • Revenue Next Year
  • PTIX N/A
  • AGMH N/A
  • P/E Ratio
  • PTIX N/A
  • AGMH N/A
  • Revenue Growth
  • PTIX N/A
  • AGMH N/A
  • 52 Week Low
  • PTIX $0.18
  • AGMH $0.04
  • 52 Week High
  • PTIX $1.87
  • AGMH $2.19
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 67.76
  • AGMH 23.98
  • Support Level
  • PTIX $0.18
  • AGMH $0.04
  • Resistance Level
  • PTIX $0.28
  • AGMH $0.06
  • Average True Range (ATR)
  • PTIX 0.04
  • AGMH 0.01
  • MACD
  • PTIX 0.01
  • AGMH 0.03
  • Stochastic Oscillator
  • PTIX 62.39
  • AGMH 4.86

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About AGMH AGM Group Holdings Inc.

AGM Group Holdings Inc is an investment holding company. The company focuses on blockchain-oriented ASIC chip design; high-end crypto miner production and fintech technology software service. It generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.

Share on Social Networks: